Trinity Biotech plc
Hedge Funds Holdings
Last updated:
Trinity Biotech plc‘s stocks are currently a part of 15 hedge funds’ portfolios, which represents 3.36% of the total amount of its stocks outstanding. This makes up a total of 4.62M shares of Trinity Biotech plc. Compared to the previous quarter, the number fell by -29.61% or -1.94M shares fewer. As for the holding position changes, 13.33% (2) of current hedge fund investors increased the number of shares held, 33.33% (5) of current holders sold a part of the shares held, and 13.33% (2) closed the holdings completely.
Hedge funds holding Trinity Biotech (Q2 2018 – Q1 2023)
| Q2 2018 | 43 |
|---|---|
| Q3 2018 | 43 |
| Q4 2018 | 38 |
| Q1 2019 | 35 |
| Q2 2019 | 32 |
| Q3 2019 | 24 |
| Q4 2019 | 23 |
| Q1 2020 | 20 |
| Q2 2020 | 24 |
| Q3 2020 | 21 |
| Q4 2020 | 23 |
| Q1 2021 | 31 |
| Q2 2021 | 27 |
| Q3 2021 | 20 |
| Q4 2021 | 19 |
| Q1 2022 | 20 |
| Q2 2022 | 18 |
| Q3 2022 | 19 |
| Q4 2022 | 20 |
| Q1 2023 | 15 |
Hedge funds changes in Trinity Biotech positions (Q2 2018 – Q1 2023)
| Q2 2018 | 4 | 10 | 13 | 4 | 12 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 8 | 15 | 4 | 12 |
| Q4 2018 | 1 | 7 | 15 | 7 | 8 |
| Q1 2019 | 0 | 10 | 11 | 2 | 12 |
| Q2 2019 | 3 | 7 | 11 | 6 | 5 |
| Q3 2019 | 2 | 4 | 9 | 10 | -1 |
| Q4 2019 | 4 | 5 | 6 | 5 | 3 |
| Q1 2020 | 1 | 4 | 6 | 4 | 5 |
| Q2 2020 | 9 | 5 | 6 | 5 | -1 |
| Q3 2020 | 4 | 7 | 4 | 7 | -1 |
| Q4 2020 | 6 | 6 | 8 | 5 | -2 |
| Q1 2021 | 11 | 2 | 12 | 3 | 3 |
| Q2 2021 | 3 | 8 | 6 | 7 | 3 |
| Q3 2021 | 2 | 5 | 7 | 9 | -3 |
| Q4 2021 | 4 | 5 | 4 | 5 | 1 |
| Q1 2022 | 3 | 5 | 6 | 2 | 4 |
| Q2 2022 | 3 | 1 | 7 | 5 | 2 |
| Q3 2022 | 2 | 2 | 6 | 1 | 8 |
| Q4 2022 | 4 | 2 | 8 | 3 | 3 |
| Q1 2023 | 0 | 2 | 5 | 2 | 6 |
Hedge funds changes in Trinity Biotech stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 29,000 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 4,000 | 0 |
| Q2 2020 | 661,000 | 26,000 |
| Q3 2020 | 141,000 | 34,000 |
| Q4 2020 | 460,000 | 145,000 |
| Q1 2021 | 602,000 | 533,000 |
| Q2 2021 | 586,000 | 426,000 |
| Q3 2021 | 422,000 | 123,000 |
| Q4 2021 | 85,000 | 73,000 |
| Q1 2022 | 59,000 | 0 |
| Q2 2022 | 42,000 | 0 |
| Q3 2022 | 21,000 | 15,000 |
| Q4 2022 | 8,485 | 17,325 |
| Q1 2023 | 0 | 16,450,000 |